An improved high-throughput lipid extraction method for the analysis of human brain lipids

Lipids

Volumn 48, Issue 3, 2013, Pages 307-318

  Abbott, Sarah K ^a   Jenner, Andrew M ^a   Mitchell, Todd W ^a   Brown, Simon H J ^a   Halliday, Glenda M ^b   Garner, Brett ^a  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Ceramide; Human brain; Lipidomics; Phosphatidylcholine; Phosphatidylethanolamine; Phosphatidylserine; Sphingomyelin; Sterol

Indexed keywords

CERAMIDE; CHLOROFORM; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; SPHINGOMYELIN; STEROL; TERT BUTYL METHYL ETHER;

ADULT; ARTICLE; BRAIN HOMOGENATE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; EXTRACTION; FOLCH EXTRACTION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIMIT OF QUANTITATION; LIPID ANALYSIS; LIPID BRAIN LEVEL; LIPID COMPOSITION; LIPID EXTRACTION; LIPIDOMICS; MALE; MASS FRAGMENTOGRAPHY; SOLVENT EXTRACTION;

AGED, 80 AND OVER; BRAIN CHEMISTRY; CHEMICAL FRACTIONATION; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LIPIDS; MALE; METHYL ETHERS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TIME FACTORS;

EID: 84878352619     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-013-3760-z     Document Type: Article

References (33)

1. Ledesma MD, Martin MG, Dotti CG (2012) Lipid changes in the aged brain: effect on synaptic function and neuronal survival. Prog Lipid Res 51:23-35
2. Conde C, Martinez M, Ballabriga A (1974) Some chemical aspects of human brain development. I. Neutral glycosphingolipids, sulfatides, and sphingomyelin. Pediatr Res 8:89-92
3. Cheng D, Jenner AM, Shui G, Cheong WF, Mitchell TW, Nealon JR, Kim WS, McCann H, Wenk MR, Halliday GM, Garner B (2011) Lipid pathway alterations in Parkinson's disease primary visual cortex. PLoS ONE 6:e17299
4. Fabelo N, Martín V, Santpere G, Marín R, Torrent L, Ferrer I, Díaz M (2011) Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease. Mol Med 17:1107-1118
5. Hejazi L, Wong JWH, Cheng D, Proschogo N, Ebrahimi D, Garner B, Don AS (2011) Mass and relative elution time profiling: two-dimensional analysis of sphingolipids in Alzheimer's disease brains. Biochem J 438:165-175
6. Garner B (2010) Lipids and Alzheimer's disease. Biochim Biophys Acta Mol Cell Biol Lipids 1801:747-749
7. Karasinska JM, Hayden MR (2011) Cholesterol metabolism in Huntington disease. Nat Rev Neurol 7:561-572
8. Schwarz E, Prabakaran S, Whitfield P, Major H, Leweke FM, Koethe D, McKenna P, Bahn S (2008) High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides. J Proteome Res 7:4266-4277
9. Eisenstein M (2011) Genetics: finding risk factors. Nature 475:S20-S22
10. Bertram L, Tanzi RE (2012) The genetics of Alzheimer's disease. Prog Mol Biol Transl Sci 107:79-100
11. Fonteh AN, Harrington RJ, Huhmer AF, Biringer RG, Riggins JN, Harrington MG (2006) Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods. Dis Markers 22:39-64
12. Blanksby SJ, Mitchell TW (2010) Advances in mass spectrometry for lipidomics. Annu Rev Anal Chem 3:433-465
13. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509
14. Cequier-Sánchez E, Rodríguez C, Ravelo AG, Zárate R (2008) Dichloromethane as a solvent for lipid extraction and assessment of lipid classes and fatty acids from samples of different natures. J Agric Food Chem 56:4297-4303
15. Carlson LA (1985) Extraction of lipids from human whole serum and lipoproteins and from rat liver tissue with methylene chloride-methanol: a comparison with extraction with chloroform-methanol. Clin Chim Acta 149:89-93
16. Fraser T, Tayler H, Love S (2008) Low-temperature improved-throughput method for analysis of brain fatty acids and assessment of their post-mortem stability. J Neurosci Methods 169:135-140
17. Fraser T, Tayler H, Love S (2010) Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease. Neurochem Res 35:503-513
18. Römisch-Margl W, Prehn C, Bogumil R, Röhring C, Suhre K, Adamski J (2012) Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics. Metabolomics 8:133-142
19. Wu H, Southam AD, Hines A, Viant MR (2008) High-throughput tissue extraction protocol for NMR- and MS-based metabolomics. Anal Biochem 372:204-212
20. Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D (2008) Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res 49:1137-1146
21. Kosicek M, Kirsch S, Bene R, Trkanjec Z, Titlic M, Bindila L, Peter-Katalinic J, Hecimovic S (2010) Nano-HPLC-MS analysis of phospholipids in cerebrospinal fluid of Alzheimer's disease patients - a pilot study. Anal Bioanal Chem 398:2929-2937
22. Kosicek M, Zetterberg H, Andreasen N, Peter-Katalinic J, Hecimovic S (2012) Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer's disease. Neurosci Lett 516:302-305
23. Bligh EG, Dyer WJ (1959) A Rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917
24. Graessler J, Schwudke D, Schwarz PEH, Herzog R, Shevchenko A, Bornstein SR (2009) Top-down lipidomics reveals ether lipid deficiency in blood plasma of hypertensive patients. PLoS ONE 4:e6261
25. Ki Ichihara, Yoneda K, Takahashi A, Hoshino N, Matsuda M (2011) Improved methods for the fatty acid analysis of blood lipid classes. Lipids 46:297-306
26. Schuhmann K, Almeida R, Baumert M, Herzog R, Bornstein SR, Shevchenko A (2012) Shotgun lipidomics on a LTQ Orbitrap mass spectrometer by successive switching between acquisition polarity modes. J Mass Spectrom 47:96-104
27. Deeley JM, Mitchell TW, Wei X, Korth J, Nealon JR, Blanksby SJ, Truscott RJW (2008) Human lens lipids differ markedly from those of commonly used experimental animals. Biochim Biophys Acta Mol Cell Biol Lipids 1781:288-298
28. Saville JT, Zhao Z, Willcox MDP, Blanksby SJ, Mitchell TW (2010) Detection and quantification of tear phospholipids and cholesterol in contact lens deposits: the effect of contact lens material and lens care solution. Invest Ophthalmol Visual Sci 51:2843-2851
29. Ejsing CS, Duchoslav E, Sampaio J, Simons K, Bonner R, Thiele C, Ekroos K, Shevchenko A (2006) Automated identification and quantification of glycerophospholipid molecular species by multiple precursor ion scanning. Anal Chem 78:6202-6214
30. Zemski Berry K, Murphy R (2004) Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids. J Am Soc Mass Spectrometry 15:1499-1508
31. Mitchell TW, Buffenstein R, Hulbert AJ (2007) Membrane phospholipid composition may contribute to exceptional longevity of the naked mole-rat (Heterocephalus glaber): a comparative study using shotgun lipidomics. Exp Gerontol 42:1053-1062
32. Ginsberg L, Rafique S, Xuereb JH, Rapoport SI, Gershfeld NL (1995) Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain. Brain Res 698:223-226
33. Han X, Holtzman DM, McKeel DW, Kelley J, Morris JC (2002) Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J Neurochem 82:809-818